XML 28 R11.htm IDEA: XBRL DOCUMENT v3.25.4
Revenues
 12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Revenues Revenues
Revenues are recognized under guidance within ASC 606, Revenue from Contracts with Customers. The following table presents the Company's disaggregated revenue for the periods presented (in thousands):
Year Ended December 31,
202520242023
ZORYVE cream 0.3%
$120,995 $85,082 $29,186 
ZORYVE foam
181,892 71,539 — 
ZORYVE cream 0.15%
68,274 9,921 — 
ZORYVE cream 0.05%
911 — — 
Total product revenue, net
372,072 166,542 29,186 
Other revenue
4,000 30,000 30,420 
Total revenues
$376,072 $196,542 $59,606 
Other revenue relates primarily to the Sato and Huadong licensing agreements. See Note 7.
Product revenue, net outside the United States represented less than 10% of the Company’s consolidated product revenue, net for the years ended December 31, 2025, 2024 and 2023.
Major customers are defined as customers that individually accounted for greater than 10% of the Company's revenue. The following table presents each major customer that accounted for more than 10% of its gross product sales.
Year Ended December 31,
% of gross product sales
202520242023
Customer A
17 %16 %13 %
Customer B
12 %12 %13 %
Customer C
11 %**
Customer D
11 %14 %21 %
Customer E
*13 %*
Customer F
**22 %
Total gross product sales from major customers
51 %55 %69 %
* Represents less than 10% of respective balance
As of December 31, 2025, amounts due from four of these customers each exceeded 10% of gross trade receivables and accounted for 60% of net trade receivables on a combined basis. As of December 31, 2024, amounts due from five of these customers each exceeded 10% of gross trade receivables and accounted for 69% of net trade receivables on a combined basis.